Experts Are Calling for a Ban on Gene Editing of Human Embryos. Here’s Why They’re Worried

When applied to human eggs, sperm and embryos, gene-editing technologies, of which CRISPR is the most precise, can alter the ...

How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...

An AI-guided gene-editing tool for more precise and safer DNA correction

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...
Hosted on MSN

Gene hacking is coming and it could rewrite what it means to be human

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and consumer-facing startups. Gene editing, once confined to rare diseases and lab ...

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the U.S. Patent and Trademark Office ...
Forbes

New Era For Gene Editing: Tech Corrects Complex DNA

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
EurekAlert!

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides

In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and ...
National Academies of Sciences%2c Engineering%2c and Medicine

Human Genome Editing: Scientific, Medical and Ethical Considerations

A multidisciplinary committee of experts studied the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine -- including human germline ...
The Caledonian-Record

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that the ...